Literature DB >> 25539902

Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

Trine Gjerløff1, Tatyana Fedorova1, Karoline Knudsen1, Ole L Munk1, Adjmal Nahimi1, Steen Jacobsen1, Erik H Danielsen2, Astrid J Terkelsen2, John Hansen3, Nicola Pavese4, David J Brooks4, Per Borghammer5.   

Abstract

Parkinson's disease is associated with early parasympathetic dysfunction leading to constipation and gastroparesis. It has been suggested that pathological α-synuclein aggregations originate in the gut and ascend to the brainstem via the vagus. Our understanding of the pathogenesis and time course of parasympathetic denervation in Parkinson's disease is limited and would benefit from a validated imaging technique to visualize the integrity of parasympathetic function. The positron emission tomography tracer 5-[(11)C]-methoxy-donepezil was recently validated for imaging acetylcholinesterase density in the brain and peripheral organs. Donepezil is a high-affinity ligand for acetylcholinesterase-the enzyme that catabolizes acetylcholine in cholinergic synapses. Acetylcholinesterase histology has been used for many years for visualizing cholinergic neurons. Using 5-[(11)C]-methoxy-donepezil positron emission tomography, we studied 12 patients with early-to-moderate Parkinson's disease (three female; age 64 ± 9 years) and 12 age-matched control subjects (three female; age 62 ± 8 years). We collected clinical information about motor severity, constipation, gastroparesis, and other parameters. Heart rate variability measurements and gastric emptying scintigraphies were performed in all subjects to obtain objective measures of parasympathetic function. We detected significantly decreased (11)C-donepezil binding in the small intestine (-35%; P = 0.003) and pancreas (-22%; P = 0.001) of the patients. No correlations were found between the (11)C-donepezil signal and disease duration, severity of constipation, gastric emptying time, and heart rate variability. In Parkinson's disease, the dorsal motor nucleus of the vagus undergoes severe degeneration and pathological α-synuclein aggregations are also seen in nerve fibres innervating the gastro-intestinal tract. In contrast, the enteric nervous system displays little or no loss of cholinergic neurons. Decreases in (11)C-donepezil binding may, therefore, represent a marker of parasympathetic denervation of internal organs, but further validation studies are needed.
© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson's disease; acetylcholinesterase; autonomic nervous system; parasympathetic nervous system; positron emission tomography

Mesh:

Substances:

Year:  2014        PMID: 25539902      PMCID: PMC4408425          DOI: 10.1093/brain/awu369

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  53 in total

1.  Expression of the non-neuronal cholinergic system in rat β-cells.

Authors:  Dick S Delbro
Journal:  Auton Neurosci       Date:  2012-01-20       Impact factor: 3.145

2.  Heart rate variability in complex regional pain syndrome during rest and mental and orthostatic stress.

Authors:  Astrid J Terkelsen; Henning Mølgaard; John Hansen; Nanna B Finnerup; Karsten Krøner; Troels S Jensen
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

3.  Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Hemraj B Dodiya; Shriram Jakate; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2012-05-01       Impact factor: 10.338

4.  Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test.

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2010-10-12       Impact factor: 4.849

5.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

6.  Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.

Authors:  Thibaud Lebouvier; Michel Neunlist; Stanislas Bruley des Varannes; Emmanuel Coron; Anne Drouard; Jean-Michel N'Guyen; Tanguy Chaumette; Maddalena Tasselli; Sébastien Paillusson; Mathurin Flamand; Jean-Paul Galmiche; Philippe Damier; Pascal Derkinderen
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

7.  Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Authors:  R Savica; J M Carlin; B R Grossardt; J H Bower; J E Ahlskog; D M Maraganore; A E Bharucha; W A Rocca
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

8.  Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease.

Authors:  C-A Haensch; H Lerch; J Jörg; S Isenmann
Journal:  Parkinsonism Relat Disord       Date:  2008-06-02       Impact factor: 4.891

9.  Glucose intolerance in Parkinson's disease.

Authors:  I J Lipman; M E Boykin; R E Flora
Journal:  J Chronic Dis       Date:  1974-12

Review 10.  Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Emanuele Cereda; Michela Barichella; Carlo Pedrolli; Catherine Klersy; Erica Cassani; Riccardo Caccialanza; Gianni Pezzoli
Journal:  Diabetes Care       Date:  2011-12       Impact factor: 19.112

View more
  43 in total

1.  Imaging in Parkinson's disease: time to look below the neck.

Authors:  A Jon Stoessl
Journal:  Brain       Date:  2015-03       Impact factor: 13.501

Review 2.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

3.  Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.

Authors:  Jeanette M Shultz; Henry Resnikoff; Viktorya Bondarenko; Valerie Joers; Andres Mejia; Heather Simmons; Marina E Emborg
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-03

Review 4.  Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.

Authors:  Joseph Classen; Jiri Koschel; Christian Oehlwein; Klaus Seppi; Peter Urban; Christian Winkler; Ullrich Wüllner; Alexander Storch
Journal:  J Neural Transm (Vienna)       Date:  2017-07-12       Impact factor: 3.575

Review 5.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

6.  Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Miki Ueda; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

Review 7.  Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 8.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

9.  Molecular imaging of cholinergic processes in prostate cancer using ¹¹C-donepezil and ¹⁸F-FEOBV.

Authors:  Morten Gersel Stokholm; Søren Høyer; Michael Borre; Dirk Bender; Steen Jakobsen; Jørgen Frøkiær; Per Borghammer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-01       Impact factor: 9.236

Review 10.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.